Long Term Debt Summary of AstraZeneca PLC

AstraZeneca PLC's latest annual long term debt in 2023 was 23.22 Billion USD , down -1.98% from previous year.
AstraZeneca PLC's latest quarterly long term debt in 2024 Q1 was 27.25 Billion USD , up 21.9% from previous quarter.
AstraZeneca PLC reported annual long term debt of 23.69 Billion USD in 2022, down -17.99% from previous year.
AstraZeneca PLC reported annual long term debt of 28.88 Billion USD in 2021, up 60.54% from previous year.
AstraZeneca PLC reported quarterly long term debt of 27.25 Billion USD for 2024 Q1, up 21.9% from previous quarter.
AstraZeneca PLC reported quarterly long term debt of 25.05 Billion USD for 2023 Q2, down -9.39% from previous quarter.

Annual Long Term Debt Chart of AstraZeneca PLC (2023 - 1990)

Historical Annual Long Term Debt of AstraZeneca PLC (2023 - 1990)

Year	Long Term Debt	Long Term Debt Growth
2023	23.22 Billion USD	-1.98%
2022	23.69 Billion USD	-17.99%
2021	28.88 Billion USD	60.54%
2020	17.99 Billion USD	10.96%
2019	16.21 Billion USD	-6.58%
2018	17.35 Billion USD	11.56%
2017	15.56 Billion USD	7.3%
2016	14.5 Billion USD	2.57%
2015	14.13 Billion USD	68.36%
2014	8.39 Billion USD	-2.22%
2013	8.58 Billion USD	-8.73%
2012	9.4 Billion USD	28.22%
2011	7.33 Billion USD	-22.51%
2010	9.47 Billion USD	0.95%
2009	9.38 Billion USD	-13.58%
2008	10.85 Billion USD	-0.19%
2007	10.87 Billion USD	900.55%
2006	1.08 Billion USD	-2.16%
2005	1.11 Billion USD	-1.42%
2004	1.12 Billion USD	271.95%
2003	303 Million USD	-7.67%
2002	328.16 Million USD	-63.87%
2001	908.39 Million USD	43.78%
2000	631.79 Million USD	-14.58%
1999	739.63 Million USD	-3.13%
1998	763.54 Million USD	-11.52%
1997	862.92 Million USD	2.0%
1996	845.97 Million USD	-0.46%
1995	849.86 Million USD	3.35%
1994	822.35 Million USD	-0.9%
1993	829.83 Million USD	-39.48%
1992	1.37 Billion USD	-57.5%
1991	3.22 Billion USD	-2.26%
1990	3.3 Billion USD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	27.22 Billion USD	-0.09%
2024 Q1	27.25 Billion USD	21.9%
2023 Q2	25.05 Billion USD	-9.39%
2023 Q1	27.64 Billion USD	16.7%
2023 Q3	22.96 Billion USD	-8.31%
2023 Q4	23.22 Billion USD	1.1%
2023 FY	23.22 Billion USD	-1.98%
2022 Q3	23.68 Billion USD	-12.76%
2022 Q4	23.69 Billion USD	0.04%
2022 Q1	28.8 Billion USD	-0.29%
2022 FY	23.69 Billion USD	-17.99%
2022 Q2	27.14 Billion USD	-5.76%
2021 Q2	24.6 Billion USD	37.64%
2021 Q4	28.88 Billion USD	-0.18%
2021 FY	28.88 Billion USD	60.54%
2021 Q3	28.93 Billion USD	17.63%
2021 Q1	17.87 Billion USD	-0.67%
2020 Q1	16.1 Billion USD	-0.68%
2020 FY	17.99 Billion USD	10.96%
2020 Q4	17.99 Billion USD	-4.05%
2020 Q3	18.75 Billion USD	20.1%
2020 Q2	15.61 Billion USD	-3.05%
2019 Q3	17.58 Billion USD	-1.61%
2019 Q2	17.86 Billion USD	0.06%
2019 FY	16.21 Billion USD	-6.58%
2019 Q1	17.85 Billion USD	2.88%
2019 Q4	16.21 Billion USD	-7.76%
2018 FY	17.35 Billion USD	11.56%
2018 Q2	15.45 Billion USD	-1.48%
2018 Q3	18.42 Billion USD	19.22%
2018 Q1	15.68 Billion USD	0.8%
2018 Q4	17.35 Billion USD	-5.77%
2017 Q1	14.56 Billion USD	0.43%
2017 Q4	15.56 Billion USD	-7.99%
2017 Q2	16.79 Billion USD	15.31%
2017 Q3	16.91 Billion USD	0.71%
2017 FY	15.56 Billion USD	7.3%
2016 Q1	14.14 Billion USD	0.05%
2016 Q4	14.5 Billion USD	-1.65%
2016 Q2	16.51 Billion USD	16.79%
2016 FY	14.5 Billion USD	2.57%
2016 Q3	14.74 Billion USD	-10.75%
2015 FY	14.13 Billion USD	68.36%
2015 Q1	8.27 Billion USD	-1.51%
2015 Q3	8.27 Billion USD	-0.33%
2015 Q4	14.13 Billion USD	70.82%
2015 Q2	8.3 Billion USD	0.4%
2014 Q2	7.57 Billion USD	0.28%
2014 Q3	7.52 Billion USD	-0.62%
2014 Q4	8.39 Billion USD	11.56%
2014 FY	8.39 Billion USD	-2.22%
2014 Q1	7.55 Billion USD	-12.05%
2013 Q1	9.32 Billion USD	-0.95%
2013 Q3	8.56 Billion USD	0.71%
2013 Q4	8.58 Billion USD	0.26%
2013 FY	8.58 Billion USD	-8.73%
2013 Q2	8.5 Billion USD	-8.73%
2012 Q3	9.34 Billion USD	27.87%
2012 Q4	9.4 Billion USD	0.66%
2012 Q1	7.37 Billion USD	0.53%
2012 FY	9.4 Billion USD	28.22%
2012 Q2	7.31 Billion USD	-0.91%
2011 Q3	7.39 Billion USD	-19.72%
2011 Q4	7.33 Billion USD	-0.76%
2011 FY	7.33 Billion USD	-22.51%
2011 Q1	9.53 Billion USD	4.77%
2011 Q2	9.21 Billion USD	-3.37%
2010 Q1	9.28 Billion USD	3706.56%
2010 FY	9.47 Billion USD	0.95%
2010 Q4	9.09 Billion USD	-4.54%
2010 Q3	9.53 Billion USD	4332.56%
2010 Q2	215 Million USD	-97.69%
2009 FY	9.38 Billion USD	-13.58%
2009 Q4	244 Million USD	-97.68%
2009 Q3	10.52 Billion USD	1.96%
2009 Q2	10.32 Billion USD	1.8%
2009 Q1	10.13 Billion USD	-6.6%
2008 Q1	11.11 Billion USD	2.21%
2008 FY	10.85 Billion USD	-0.19%
2008 Q2	11.03 Billion USD	-0.76%
2008 Q3	10.82 Billion USD	-1.87%
2008 Q4	10.85 Billion USD	0.27%
2007 Q1	1.08 Billion USD	0.0%
2007 FY	10.87 Billion USD	900.55%
2007 Q2	1.05 Billion USD	-2.76%
2007 Q3	8.99 Billion USD	750.9%
2007 Q4	10.87 Billion USD	20.93%
2006 Q3	1.08 Billion USD	4.11%
2006 FY	1.08 Billion USD	-2.16%
2006 Q4	1.08 Billion USD	-0.18%
2006 Q1	1.08 Billion USD	-2.16%
2006 Q2	1.04 Billion USD	-3.77%
2005 FY	1.11 Billion USD	-1.42%
2005 Q1	1.11 Billion USD	7.86%
2005 Q2	1.16 Billion USD	4.68%
2005 Q3	1.12 Billion USD	-3.53%
2005 Q4	1.11 Billion USD	-0.98%
2004 Q3	1.09 Billion USD	-0.18%
2004 Q2	1.09 Billion USD	259.67%
2004 FY	1.12 Billion USD	271.95%
2004 Q1	305 Million USD	0.66%
2004 Q4	1.03 Billion USD	-5.94%
2003 Q3	- USD	-100.0%
2003 FY	303 Million USD	-7.67%
2003 Q4	303 Million USD	0.0%
2003 Q2	323.89 Million USD	0.0%
2003 Q1	- USD	-100.0%
2002 Q2	338.92 Million USD	0.0%
2002 Q3	- USD	-100.0%
2002 FY	328.16 Million USD	-63.87%
2002 Q4	328 Million USD	0.0%
2002 Q1	- USD	-100.0%
2001 Q4	908.39 Million USD	0.0%
2001 Q1	- USD	-100.0%
2001 Q2	642.71 Million USD	0.0%
2001 Q3	- USD	-100.0%
2001 FY	908.39 Million USD	43.78%
2000 FY	631.79 Million USD	-14.58%
2000 Q1	- USD	-100.0%
2000 Q2	749.09 Million USD	0.0%
2000 Q3	- USD	-100.0%
2000 Q4	631.79 Million USD	0.0%
1999 Q2	749 Million USD	0.0%
1999 Q3	741 Million USD	-1.07%
1999 Q4	739.63 Million USD	-0.18%
1999 FY	739.63 Million USD	-3.13%
1998 Q2	843 Million USD	0.0%
1998 FY	763.54 Million USD	-11.52%
1998 Q4	763.54 Million USD	0.0%
1997 FY	862.92 Million USD	2.0%
1997 Q4	862.92 Million USD	0.0%
1996 FY	845.97 Million USD	-0.46%
1996 Q4	845.97 Million USD	0.0%
1995 Q4	849.86 Million USD	0.0%
1995 Q2	877 Million USD	0.0%
1995 FY	849.86 Million USD	3.35%
1994 Q4	822.35 Million USD	0.0%
1994 FY	822.35 Million USD	-0.9%
1993 Q4	829.83 Million USD	0.0%
1993 FY	829.83 Million USD	-39.48%
1992 FY	1.37 Billion USD	-57.5%
1991 FY	3.22 Billion USD	-2.26%
1990 FY	3.3 Billion USD	0.0%

Peer Long Term Debt Comparison of AstraZeneca PLC

Name	Long Term Debt	Long Term Debt Difference
Amgen Inc.	63.17 Billion USD	63.239%
Biogen Inc.	7.18 Billion USD	-223.057%
Gilead Sciences, Inc.	23.18 Billion USD	-0.142%
MIRA Pharmaceuticals, Inc.	- USD	-Infinity%
Scilex Holding Company	17.03 Million USD	-136195.34%
Scilex Holding Company	17.03 Million USD	-136195.34%

Global Stocks Search

AstraZeneca PLC (AZN)

Long Term Debt Summary of AstraZeneca PLC

Annual Long Term Debt Chart of AstraZeneca PLC (2023 - 1990)

Historical Annual Long Term Debt of AstraZeneca PLC (2023 - 1990)

Peer Long Term Debt Comparison of AstraZeneca PLC